Appointment of Architectural Design Team for The Fleming Centre, St Mary's Hospital, London
Contract Value:
GBP 3M -
Notice Type:
Contract Notice
Published Date:
08 July 2024
Closing Date:
07 August 2024
Location(s):
UKI33 Kensington & Chelsea and Hammersmith & Fulham (UK UNITED KINGDOM)
Description:
Appointment of an architectural design team for The Fleming Centre at St Mary's Hospital, London, to drive global change in antimicrobial research and public engagement, with a completion target by Q1 2029 and an estimated project cost of £30,000,000.
Appointment of Architectural Design Team for The Fleming Centre, St Mary's Hospital, London. Imperial College Healthcare NHS Trust (“ICHT”, the "Authority") is issuing this invitation for the procurement and appointment of an Architectural Design Team for The Fleming Centre, St Mary’s Hospital, London.
This procurement will be run via a Competitive with Negotiation procedure under the Public Contracts Regulations 2015 ("PCR").
The purpose of this procurement exercise is for the Imperial College Healthcare NHS Trust (ICHT) to appoint an architectural design team to provide architectural and supporting specialist design services covering RIBA Stages 2-7 for their Fleming Centre project located at The Bays site, St Mary’s Hospital, London.
The Fleming Centre, a collaborative initiative between the Imperial College Healthcare NHS Trust (ICHT) and the Imperial College London (ICL), will be a major new contributor to the UK’s vision that by 2040 antimicrobial resistance (AMR) will be effectively contained, controlled, and mitigated. It will be a place of discovery, innovation and, above all, the place that drives global change, from the birthplace of antibiotics at St. Mary’s Hospital, where Sir Alexander Fleming first discovered penicillin. High-profile work by the Trust and College, throughout the Covid-19 pandemic has transformed the value of university and clinical research on infection, and the application of this research in acute care.
To do this effectively, the Centre will combine three major strands of activity:
• world class scientific and clinical research; • on-site public engagement; and • convening power and policy work relating to behaviour change.
The project is expected to be completed by Q1 2029, with an opening and ‘soft launch’ in Q4 2028, coinciding with the centenary of Fleming’s discovery of penicillin. The anticipated build cost for the project is £30,000,000, with a contract term of four (4) years.
The Fleming Centre will be of national and international importance as a hub for antimicrobial research (AMR), policy development and public engagement. It will be a major new contributor to the UK’s vision that by 2040 AMR will be effectively contained, controlled, and mitigated. It will be a place of discovery, innovation and, above all, the place that drives global change, from the birthplace of antibiotics.
Imperial College Healthcare NHS Trust (“ICHT”, the "Authority") is issuing this invitation for the procurement and appointment of an Architectural Design Team for The Fleming Centre, St Mary’s Hospital, London.
This procurement will be run via a Competitive with Negotiation procedure under the Public Contracts Regulations 2015 ("PCR").
The purpose of this procurement exercise is for the Imperial College Healthcare NHS Trust (ICHT) to appoint an architectural design team to provide architectural and supporting specialist design services covering RIBA Stages 2-7 for their Fleming Centre project located at The Bays site, St Mary’s Hospital, London.
The Fleming Centre, a collaborative initiative between the Imperial College Healthcare NHS Trust (ICHT) and the Imperial College London (ICL), will be a major new contributor to the UK’s vision that by 2040 antimicrobial resistance (AMR) will be effectively contained, controlled, and mitigated. It will be a place of discovery, innovation and, above all, the place that drives global change, from the birthplace of antibiotics at St. Mary’s Hospital, where Sir Alexander Fleming first discovered penicillin. High-profile work by the Trust and College, throughout the Covid-19 pandemic has transformed the value of university and clinical research on infection, and the application of this research in acute care.
To do this effectively, the Centre will combine three major strands of activity:
• world class scientific and clinical research; • on-site public engagement; and • convening power and policy work relating to behaviour change.
The project is expected to be completed by Q1 2029, with an opening and ‘soft launch’ in Q4 2028, coinciding with the centenary of Fleming’s discovery of penicillin. The anticipated build cost for the project is £30,000,000, with a contract term of four (4) years.
The Fleming Centre will be of national and international importance as a hub for antimicrobial research (AMR), policy development and public engagement. It will be a major new contributor to the UK’s vision that by 2040 AMR will be effectively contained, controlled, and mitigated. It will be a place of discovery, innovation and, above all, the place that drives global change, from the birthplace of antibiotics.
Potential Suppliers are required to register their interest at https://www.architecture.com/awards-and-competitions-landing-page/competitions-landing-page/the-fleming-centre by 12:00 noon, Wednesday, 7th August 2024. Once registered, participants will be sent an individual unique secure link and unique registration number (URN) from RIBASubmit, where they will be able to download the competition documents and upload their submissions. The full details of the project and the procurement process, including timescales is included in the competition documents.
PLEASE NOTE: The estimated launch date of this opportunity will be Wednesday, 4th September 2024 and the tender will be run via: https://www.architecture.com/awards-and-competitions-landing-page/competitions-landing-page/the-fleming-centre.